NCT06861023 Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
| NCT ID | NCT06861023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Melanoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2025-01-15 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Melanomas of the nail bed are often diagnosed at the locally advanced stage. The standard treatment was amputation of the finger or toe, but it has now been established that enlarged excision of the nail plate is sufficient under certain conditions. Reconstruction of the nail system can be performed by several techniques. Here, the investigators present a series of patients reconstructed by INTEGRA (dermal matrix) and skin graft
Eligibility Criteria
Inclusion Criteria: * Patients who have undergone enlarged resection of the nail apparatus with immediate or delayed reconstruction in the setting of acral melanoma of the fingers or toes. Exclusion Criteria: * Patients who have amputation, opposition of the pateint to the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06861023 clinical trial?
This trial is open to participants of all sexes, studying Melanoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06861023 currently recruiting?
Yes, NCT06861023 is actively recruiting participants. Contact the research team at lupon.e@chu-nice.fr for enrollment information.
Where is the NCT06861023 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06861023 clinical trial?
NCT06861023 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.